Natalizumab treatment in pediatric multiple sclerosis: a case report

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
Giovanna BorrielloC Pozzilli

Abstract

Pediatric multiple sclerosis (MS) with manifestations before 16 years of age occurs in 0.4-10.5% of whole MS population. The initial course of the disease is relapsing-remitting with a relapse rate generally higher than that of adults, less than 3% have a primary progressive form. Some recent reports have shown that Interferon beta (IFNbeta) has a strong effect in reducing the relapse rate in children with MS and is well tolerated. We report a 12-year-old girl with MS and a high relapse rate from the onset. Frequent magnetic resonance imaging (MRI) detected persisting inflammatory activity and increase of lesion burden. She continued to present acute relapses and progression of disability in spite of a treatment with IFNbeta-1a at different dosages and the addition of pulse IV steroid treatment. Then, we opted for Natalizumab treatment, recently approved as a monotherapy for patients with MS who experienced inadequate response to other disease modifying therapies and never used till now in pediatric MS. Our patient showed a complete response to Natalizumab with clinical and MRI suppression of disease activity.

References

Nov 26, 2003·Neurology·D S GoodinUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Aug 4, 2004·Brain : a Journal of Neurology·Yann MikaeloffUNKNOWN KIDMUS Study Group on Radiology
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Apr 18, 2007·Neurology·Jin S HahnUNKNOWN International Pediatric MS Study Group
Apr 18, 2007·Neurology·J M NessUNKNOWN International Pediatric MS Study Group
Apr 18, 2007·Neurology·D PohlUNKNOWN International Pediatric MS Study Group
Jun 15, 2007·Journal of the Neurological Sciences·Mark S Freedman
Jun 22, 2007·The New England Journal of Medicine·Christel RenouxUNKNOWN Adult Neurology Departments KIDMUS Study Group
Sep 21, 2007·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Yann MikaeloffUNKNOWN KIDSEP study group of the French Neuropediatric Society

❮ Previous
Next ❯

Citations

Dec 12, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tanuja Chitnis
Jan 1, 2014·Clinical Neurology and Neurosurgery·Silvia N Tenembaum
Aug 21, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Norman PutzkiSebastian Rauer
Feb 26, 2010·Annals of Indian Academy of Neurology·Yashma PatelLauren Krupp
May 6, 2011·Theranostics·Gang Niu, Xiaoyuan Chen
Oct 30, 2015·Expert Review of Neurotherapeutics·Giovanna VitalitiRaffaele Falsaperla
Feb 19, 2010·Expert Opinion on Pharmacotherapy·Nancy L KuntzUNKNOWN Network of US Pediatric Multiple Sclerosis Centers
Oct 2, 2012·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Carmen Arnal-GarciaCelia Oreja-Guevara
Dec 31, 2011·Journal of the Neurological Sciences·Silvia Tenembaum
May 18, 2010·Clinical Neurology and Neurosurgery·Silvia N Tenembaum
Aug 13, 2015·Human Vaccines & Immunotherapeutics·Giovanna VitalitiRaffaele Falsaperla
Jun 25, 2009·Developmental Medicine and Child Neurology·Richard E Appleton, Mike Boggild
Mar 18, 2009·Biochimica Et Biophysica Acta·Carl G GahmbergMikaela Grönholm
Mar 7, 2015·La Presse médicale·Sona Narula, Brenda Banwell
Jun 4, 2013·The Journal of Pediatrics·Keith Van Haren, Emmanuelle Waubant
Jun 18, 2016·Current Treatment Options in Neurology·Marta Simone, Tanuja Chitnis
Dec 8, 2011·Multiple Sclerosis : Clinical and Laboratory Research·T ChitnisUNKNOWN International Pediatric Multiple Sclerosis Study Group
Aug 6, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Angelo GhezziRogier Hintzen
Oct 13, 2012·Arquivos de neuro-psiquiatria·Alessandro FinkelsztejnDarwin Vizcarra
Jul 30, 2014·Multiple Sclerosis : Clinical and Laboratory Research·Peter HuppkeJutta Gärtner
Aug 24, 2012·Journal of Child Neurology·E Ann Yeh, Bianca Weinstock-Guttman
Feb 13, 2013·Multiple Sclerosis : Clinical and Laboratory Research·A GhezziUNKNOWN Italian MS Study Group
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·E Ann Yeh, Bianca Weinstock-Guttman
Dec 24, 2010·Therapeutic Advances in Neurological Disorders·Angelo Ghezzi
Jan 13, 2011·Nature Reviews. Neurology·Brenda BanwellMarc Tardieu
Oct 15, 2009·Nature Reviews. Neurology·E Ann YehUNKNOWN US Network of Pediatric Multiple Sclerosis Centers of Excellence
Mar 12, 2010·The Neurologist·Sunita Venkateswaran, Brenda Banwell
Oct 5, 2010·Current Opinion in Pediatrics·Silvia N Tenembaum
Apr 14, 2012·Paediatric Drugs·E Ann Yeh
Jul 30, 2019·Neurology. Neuroimmunology and Neuroinflammation·Angelo GhezziPaolo Gallo
Dec 14, 2011·Expert Review of Clinical Immunology·Maria Chiara G Monaco, Eugene O Major
Apr 14, 2016·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O V BykovaA N Boiko
Aug 28, 2019·Neurology. Neuroimmunology and Neuroinflammation·Angelo GhezziPaolo Gallo
Sep 23, 2009·Expert Review of Neurotherapeutics·Valentina Tomassini, Jacqueline Palace

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.